Shandong Jincheng Pharmaceutical and Chemical Co Ltd Net Asset Quality Index
Shandong Jincheng Pharmaceutical and Chemical Co Ltd net asset quality index. Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a Net Asset Quality Index of 72.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥5.21 Billion minus total liabilities of CN¥1.43 Billion yields net assets of CN¥3.78 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check cash flow quality index of Shandong Jincheng Pharmaceutical and Che to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
Net asset quality index of Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2025. This chart shows how Shandong Jincheng Pharmaceutical and Chemical Co Ltd's Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of March 2026, the index stands at 72.6%, representing net assets of CN¥3.78 Billion against total assets of CN¥5.21 Billion CNY. See 300233 book value for net asset value and shareholders' equity analysis.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Net Asset Quality Index by Year (2008–2025)
Shandong Jincheng Pharmaceutical and Chemical Co Ltd net asset quality index by year from 2008 to 2025. The table below presents the year-by-year Net Asset Quality Index for Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Shandong Jincheng Pharmaceutical and Che (300233) market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 71.7% | CN¥3.72 Billion | CN¥5.19 Billion | CN¥1.47 Billion | ▲ +3.4 pp |
| 2024 | 68.4% | CN¥3.83 Billion | CN¥5.60 Billion | CN¥1.77 Billion | ▲ +4.5 pp |
| 2023 | 63.9% | CN¥3.78 Billion | CN¥5.92 Billion | CN¥2.14 Billion | ▲ +1.1 pp |
| 2022 | 62.8% | CN¥3.66 Billion | CN¥5.83 Billion | CN¥2.17 Billion | ▼ -2.4 pp |
| 2021 | 65.2% | CN¥3.44 Billion | CN¥5.28 Billion | CN¥1.84 Billion | ▼ -4.1 pp |
| 2020 | 69.3% | CN¥3.47 Billion | CN¥5.00 Billion | CN¥1.53 Billion | ▼ -3.7 pp |
| 2019 | 73.0% | CN¥4.08 Billion | CN¥5.59 Billion | CN¥1.51 Billion | ▼ -4.3 pp |
| 2018 | 77.3% | CN¥4.09 Billion | CN¥5.29 Billion | CN¥1.20 Billion | ▼ -3.0 pp |
| 2017 | 80.3% | CN¥3.94 Billion | CN¥4.90 Billion | CN¥966.24 Million | ▲ +13.6 pp |
| 2016 | 66.6% | CN¥1.50 Billion | CN¥2.26 Billion | CN¥752.68 Million | ▲ +1.0 pp |
| 2015 | 65.6% | CN¥1.31 Billion | CN¥2.00 Billion | CN¥685.95 Million | ▲ +3.1 pp |
| 2014 | 62.5% | CN¥1.12 Billion | CN¥1.79 Billion | CN¥668.61 Million | ▼ -2.3 pp |
| 2013 | 64.8% | CN¥1.02 Billion | CN¥1.58 Billion | CN¥554.11 Million | ▼ -1.5 pp |
| 2012 | 66.4% | CN¥975.57 Million | CN¥1.47 Billion | CN¥494.26 Million | ▼ -2.2 pp |
| 2011 | 68.6% | CN¥958.84 Million | CN¥1.40 Billion | CN¥439.36 Million | ▲ +29.4 pp |
| 2010 | 39.2% | CN¥375.33 Million | CN¥957.95 Million | CN¥582.62 Million | ▼ -1.5 pp |
| 2009 | 40.6% | CN¥281.53 Million | CN¥692.56 Million | CN¥411.04 Million | ▲ +6.1 pp |
| 2008 | 34.6% | CN¥216.49 Million | CN¥626.16 Million | CN¥409.67 Million | — |